“BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA”. 2022. Mediterranean Journal of Hematology and Infectious Diseases 15 (1): e2023001. https://doi.org/10.4084/MJHID.2023.001.